City News Live - Health > Hematology News

N/A

FDA Approves Human Thrombin For Topical Use In Surgery
August 31, 2007 08:00:00

The U.S. Food and Drug Administration approved Evithrom (human thrombin), a blood-clotting protein used to help control bleeding during surgery.Evithrom is the first human thrombin approved since 1954 and is the only product currently licensed. It is derived from human plasma obtained from carefully screened and tested U.S. donors and has undergone steps to further reduce the risk for transfusion-transmitted diseases. [click link for full article] -�[Read�more]

N/A

Campaign 08: Candidates Broaden Discussion at Armstrong Cancer Forum
August 30, 2007 20:48:00

CEDAR RAPIDS, Iowa -- Only six of the 17 declared candidates for President showed up at a two-day forum designed to bring cancer care to the forefront of campaign issues, but the discussion broadened into questions of overall health care. -�[Read�more]

N/A

Missing Gene May Spark Imatinib Resistance in Philadelphia Chromosome-positive ALL
August 30, 2007 18:25:25

MEMPHIS, Tenn. -- When imatinib (Gleevec) therapy fails in Philadelphia chromosome-positive acute lymphocytic leukemia (ALL), it may be because the B-cells involved lack a critical tumor suppressor gene, researchers here said. -�[Read�more]

N/A

Pharmions Oral Azacitidine Granted Fast Track Status For Myelodysplastic Syndromes
August 30, 2007 07:00:00

Pharmion Corporation (Nasdaq: PHRM) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for oral Azacitidine in the treatment of Myelodysplastic Syndromes (MDS). Fast Track programs are designed to facilitate the development and expedite the review of new drugs that are intended to treat serious or life-threatening conditions and that demonstrate the potential to address unmet medical needs. [click link for full article] -�[Read�more]

N/A	Genes Promoting Lung Cancer May Not Normalize When Smoking Stops August 29, 2007 16:08:59 VANCOUVER, British Columbia -- For some genes involved in the development of lung cancer, smoking may be forever, according to researchers here. -�[Read�more]

N/A	Biologics in Rheumatoid Arthritis Linked to Skin Cancer Only August 29, 2007 11:00:00 WICHITA, Kan. -- Rheumatoid arthritis patients who took TNF-α blockers were at increased the risk for melanoma and other skin cancers, but not for solid tumors or lymphomas. -�[Read�more]

N/A

FDA Approves New Roche West Nile Virus Blood Screening Test
August 29, 2007 07:00:00

Roche Diagnostics announced that the US Food & Drug Administration (FDA) today approved its biologics license application for the companys test for direct detection of West Nile Virus in donated human blood and plasma. West Nile virus, which can cause serious health issues, is transmitted to humans most often through mosquito bites, but can also less commonly be transmitted by transfusion of infected blood or blood products. [click link for full article] -�[Read�more]

N/A	Human Thrombin Gets FDA Approval August 28, 2007 21:10:08 ROCKVILLE, Md. -- The FDA today allowed a human thrombin (Evithrom) on the market after the risk of transfusion-transmitted viral infection kept it on the sidelines for more than a half-century. -�[Read�more]

N/A	Hypnosis Before Surgery Dulls Pain Later August 28, 2007 20:01:08 NEW YORK -- Presurgical hypnosis may improve pain control during and after breast cancer surgery and cut costs as well, researchers said. -�[Read�more]

N/A	H. pylori Cancer Risk Tracked to Specific Genotype August 28, 2007 20:01:02 LYON, France -- The severity of precancerous lesions tracks to specific bacterial strains, investigators here reported, strengthening the association between Helicobacter pylori infection and gastric cancer. -�[Read�more]

N/A

News From The Journal Of Clinical Investigation
August 28, 2007 18:00:00

System overload: infusion of IgG helps clear therapeutic and imaging antibodies from the circulationThe use of monoclonal IgG antibodies attached to toxins or radioactive substances for treating and imaging cancer is currently limited by the ability of IgG to remain in the blood for a long time because this decreases the tumor-to-background contrast and increases normal tissue toxicity. [click link for full article] -�[Read�more]

N/A	Intact Cell Organization Resists Oncogenic Activity August 28, 2007 16:50:02 HELSINKI -- Breast cancer may spring from the loss of cellular architecture that forms a barrier against oncogenes, investigators here reported. -�[Read�more]

N/A

Protalix BioTherapeutics Treats First Patient In Phase III Clinical Trial Of PrGCD
August 28, 2007 07:00:00

Protalix BioTherapeutics, Inc. (Amex: PLX), announced that it has treated the first patient in its phase III clinical trial of the Companys lead product candidate, prGCD, a proprietary plant cell expressed recombinant form of human Glucocerebrosidase (GCD) for the treatment of Gaucher disease, a lysosomal storage disorder in humans. The phase III clinical trial will take place in centers in the United States, Israel and other locations worldwide. [click link for full article] -�[Read�more]

N/A	Cervical Cancer Screening Goes Do-It-Yourself August 27, 2007 20:04:00 VANCOUVER, British Columbia -- Asking patients to collect their own vaginal specimens for HPV testing proved an effective initial screening method among high-risk women, researchers here found. -�[Read�more]

N/A

Response By American College Of Medical Genetics To New FDA Labeling Decision For Warfarin
August 27, 2007 20:00:00

On August 16, the Food and Drug Administration approved new labeling information for the blood-thinner warfarin, sold under the brand name Coumadin. The new label suggests that one can prescribe higher or lower doses that may be safer for patients with variations in two genes, CYP2C9 or VKORC1. These variations can be learned through genetic testing, which may be a useful tool in determining appropriate dosing levels for individual patients and lower risks of bleeding complications. [click link for full article] -�[Read�more]

N/A	High Rate of Head-and-Neck Cancer in Women Pinned to Smoking August 27, 2007 17:31:59 ROCKVILLE. Md. -- Women appear to be particularly vulnerable to head-and-neck cancer from smoking, according to National Cancer Institute researchers. -�[Read�more]

N/A	HPV Vaccine May Stem Incidence of Throat Cancer August 27, 2007 15:10:04 HOUSTON -- Human papillomavirus infections are likely buoying up oropharyngeal cancer rates while other head and neck cancers decline, researchers said. -�[Read�more]

N/A

Wyeth Receives Approval From European Medicines Agency For New BeneFIX Features
August 26, 2007 07:00:00

Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), announced that it has received approval from the European Medicines Agency (EMEA) for new enhancements for BeneFIX® nonacog alfa (Recombinant Coagulation Factor IX). These enhancements are designed to offer patients a simpler and more convenient preparation process compared with the original BeneFIX preparation process. [click link for full article] -�[Read�more]

N/A	APA: Bone-Marrow Transplantation May Slow Childhood Development August 24, 2007 17:45:31 SAN FRANCISCO -- Infants who undergo bone-marrow transplantation may pay a price in a decline in communication and other developmental skills. -�[Read�more]

N/A	Continuous Local Anesthesia Aids Postop Pain and Recovery August 24, 2007 17:14:03 PARIS -- Anesthetic infusion directly into the wound after colorectal cancer surgery may improve pain control and speed recovery, researchers found. -�[Read�more]

Hematology News

RSS Feeds

Links Sort by: PageRank | Date | Hits | Alphabetical